AAAAAA

   
Results: 1-18 |
Results: 18
IS AXILLARY LYMPH-NODE DISSECTION INDICATED FOR EARLY-STAGE BREAST-CANCER - A DECISION-ANALYSIS
Authors: PROSNITZ LR PARMIGIANI G WINER EP TEBALDI C IGLEHART JD BERRY DA
Citation: Lr. Prosnitz et al., IS AXILLARY LYMPH-NODE DISSECTION INDICATED FOR EARLY-STAGE BREAST-CANCER - A DECISION-ANALYSIS, European journal of cancer, 34, 1998, pp. 53-53
ORAL 5-FU ANALOGS IN THE TREATMENT OF BREAST-CANCER
Authors: BUNNELL CA WINER EP
Citation: Ca. Bunnell et Ep. Winer, ORAL 5-FU ANALOGS IN THE TREATMENT OF BREAST-CANCER, Oncology, 12(10), 1998, pp. 39-43
CANCER PAIN SURVEY - PATIENT-CENTERED ISSUES IN CONTROL
Authors: THOMASON TE MCCUNE JS BERNARD SA WINER EP TREMONT S LINDLEY CM
Citation: Te. Thomason et al., CANCER PAIN SURVEY - PATIENT-CENTERED ISSUES IN CONTROL, Journal of pain and symptom management, 15(5), 1998, pp. 275-284
SEQUENCE-ANALYSIS OF BRCA1 AND BRCA2 - CORRELATION OF MUTATIONS WITH FAMILY HISTORY AND OVARIAN-CANCER RISK
Authors: FRANK TS MANLEY SA OLOPADE OI CUMMINGS S GARBER JE BERNHARDT B ANTMAN K RUSSO D WOOD ME MULLINEAU L ISAACS C PESHKIN B BUYS S VENNE V ROWLEY PT LOADER S OFFIT K ROBSON M HAMPEL H BRENER D WINER EP CLARK S WEBER B STRONG LC RIEGER P MCCLURE M WARD BE SHATTUCKEIDENS D OLIPHANT A SKOLNICK MH THOMAS A
Citation: Ts. Frank et al., SEQUENCE-ANALYSIS OF BRCA1 AND BRCA2 - CORRELATION OF MUTATIONS WITH FAMILY HISTORY AND OVARIAN-CANCER RISK, Journal of clinical oncology, 16(7), 1998, pp. 2417-2425
QUALITY-OF-LIFE AND PREFERENCES FOR TREATMENT FOLLOWING SYSTEMIC ADJUVANT THERAPY FOR EARLY-STAGE BREAST-CANCER
Authors: LINDLEY C VASA S SAWYER WT WINER EP
Citation: C. Lindley et al., QUALITY-OF-LIFE AND PREFERENCES FOR TREATMENT FOLLOWING SYSTEMIC ADJUVANT THERAPY FOR EARLY-STAGE BREAST-CANCER, Journal of clinical oncology, 16(4), 1998, pp. 1380-1387
TESTING FOR THE BRCA1 AND BRCA2 BREAST-OVARIAN CANCER SUSCEPTIBILITY GENES - A DECISION-ANALYSIS
Authors: TENGS TO WINER EP PADDOCK S AGUILARCHAVEZ O BERRY DA
Citation: To. Tengs et al., TESTING FOR THE BRCA1 AND BRCA2 BREAST-OVARIAN CANCER SUSCEPTIBILITY GENES - A DECISION-ANALYSIS, Medical decision making, 18(4), 1998, pp. 365-375
COMPLICATIONS OF AXILLARY LYMPH-NODE DISSECTION FOR CARCINOMA OF THE BREAST - A REPORT BASED ON A PATIENT SURVEY
Authors: WARMUTH MA BOWEN G PROSNITZ LR CHU L BROADWATER G PETERSON B LEIGHT G WINER EP
Citation: Ma. Warmuth et al., COMPLICATIONS OF AXILLARY LYMPH-NODE DISSECTION FOR CARCINOMA OF THE BREAST - A REPORT BASED ON A PATIENT SURVEY, Cancer, 83(7), 1998, pp. 1362-1368
OVERESTIMATION OF HEREDITARY BREAST-CANCER RISK
Authors: IGLEHART JD MIRON A RIMER BK WINER EP BERRY D SHILDKRAUT JM
Citation: Jd. Iglehart et al., OVERESTIMATION OF HEREDITARY BREAST-CANCER RISK, Annals of surgery, 228(3), 1998, pp. 375-383
PHARMACOKINETICS AND CLINICAL IMPACT OF ALL-TRANS-RETINOIC ACID IN METASTATIC BREAST-CANCER - A PHASE-II TRIAL
Authors: SUTTON LM WARMUTH MA PETROS WP WINER EP
Citation: Lm. Sutton et al., PHARMACOKINETICS AND CLINICAL IMPACT OF ALL-TRANS-RETINOIC ACID IN METASTATIC BREAST-CANCER - A PHASE-II TRIAL, Cancer chemotherapy and pharmacology, 40(4), 1997, pp. 335-341
A REVIEW OF HEREDITARY BREAST-CANCER - FROM SCREENING TO RISK FACTOR MODIFICATION
Authors: WARMUTH MA SUTTON LM WINER EP
Citation: Ma. Warmuth et al., A REVIEW OF HEREDITARY BREAST-CANCER - FROM SCREENING TO RISK FACTOR MODIFICATION, The American journal of medicine, 102(4), 1997, pp. 407-415
REDUCED RATES OF METABOLISM AND DECREASED PHYSICAL-ACTIVITY IN BREAST-CANCER PATIENTS RECEIVING ADJUVANT CHEMOTHERAPY
Authors: DEMARKWAHNEFRIED W HARS V CONAWAY MR HAVLIN K RIMER BK MCELVEEN G WINER EP
Citation: W. Demarkwahnefried et al., REDUCED RATES OF METABOLISM AND DECREASED PHYSICAL-ACTIVITY IN BREAST-CANCER PATIENTS RECEIVING ADJUVANT CHEMOTHERAPY, The American journal of clinical nutrition, 65(5), 1997, pp. 1495-1501
WEIGHT-GAIN IN WOMEN DIAGNOSED WITH BREAST-CANCER
Authors: DEMARKWAHNEFRIED W RIMER BK WINER EP
Citation: W. Demarkwahnefried et al., WEIGHT-GAIN IN WOMEN DIAGNOSED WITH BREAST-CANCER, Journal of the American Dietetic Association, 97(5), 1997, pp. 519
FACTORS CONTRIBUTING TO PATIENT SATISFACTION WITH BREAST RECONSTRUCTION USING SILICONE GEL IMPLANTS
Authors: FEEFULKERSON K CONAWAY MR WINER EP FULKERSON CC RIMER BK GEORGIADE G
Citation: K. Feefulkerson et al., FACTORS CONTRIBUTING TO PATIENT SATISFACTION WITH BREAST RECONSTRUCTION USING SILICONE GEL IMPLANTS, Plastic and reconstructive surgery, 97(7), 1996, pp. 1420-1426
ORAL VINORELBINE (NAVELBINE) IN THE TREATMENT OF ADVANCED BREAST-CANCER
Authors: WINER EP CHU L SPICER DV
Citation: Ep. Winer et al., ORAL VINORELBINE (NAVELBINE) IN THE TREATMENT OF ADVANCED BREAST-CANCER, Seminars in oncology, 22(2), 1995, pp. 72-79
PHARMACOKINETIC, BIOAVAILABILITY, AND FEASIBILITY STUDY OF ORAL VINORELBINE IN PATIENTS WITH SOLID TUMORS
Authors: ROWINSKY EK NOE DA TRUMP DL WINER EP LUCAS VS WARGIN WA HOHNEKER JA LUBEJKO B SARTORIUS SE ETTINGER DS DONEHOWER RC
Citation: Ek. Rowinsky et al., PHARMACOKINETIC, BIOAVAILABILITY, AND FEASIBILITY STUDY OF ORAL VINORELBINE IN PATIENTS WITH SOLID TUMORS, Journal of clinical oncology, 12(9), 1994, pp. 1754-1763
QUALITY-OF-LIFE RESEARCH IN PATIENTS WITH BREAST-CANCER
Authors: WINER EP
Citation: Ep. Winer, QUALITY-OF-LIFE RESEARCH IN PATIENTS WITH BREAST-CANCER, Cancer, 74(1), 1994, pp. 410-415
SILICONE CONTROVERSY - A SURVEY OF WOMEN WITH BREAST-CANCER AND SILICONE IMPLANTS
Authors: WINER EP FEEFULKERSON K FULKERSON CC GEORGIADE G CATOE KE CONAWAY M BRUNATTI C HOLMES V RIMER BK
Citation: Ep. Winer et al., SILICONE CONTROVERSY - A SURVEY OF WOMEN WITH BREAST-CANCER AND SILICONE IMPLANTS, Journal of the National Cancer Institute, 85(17), 1993, pp. 1407-1411
WHY WOMEN GAIN WEIGHT WITH ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER
Authors: DEMARKWAHNEFRIED W WINER EP RIMER BK
Citation: W. Demarkwahnefried et al., WHY WOMEN GAIN WEIGHT WITH ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER, Journal of clinical oncology, 11(7), 1993, pp. 1418-1429
Risultati: 1-18 |